1. Microb Drug Resist. 2022 Mar;28(3):288-292. doi: 10.1089/mdr.2021.0031. Epub 
2022 Jan 4.

Escherichia coli ST471 Producing VIM-4 Metallo-β-Lactamase in Colombia.

Rada AM(1)(2), Correa A(3)(4), Restrepo E(2), Capataz C(5).

Author information:
(1)Department of Microbiology, Bacteria and Cáncer Group, University of 
Antioquia, Medellín, Colombia.
(2)Facultad de Ciencias de la Salud, Biociencias Group, Institución 
Universitaria Colegio Mayor de Antioquia, Medellín, Colombia.
(3)Facultad de Ciencias Básicas, Universidad Santiago de Cali, Cali, Colombia.
(4)Clínica Imbanaco, Cali, Colombia.
(5)Fundación Clínica del Norte, Bello, Colombia.

An Escherichia coli isolate sequence-type 471 (ST471) producing Verona 
integron-encoded metallo-β-lactamases (VIM)-4 was recovered from a rectal swab 
in a patient without travel records with osteomyelitis in Colombia. The isolate 
carried a class 1 integron-borne blaVIM-4 gene with a 170-bp duplication in the 
3' end of the gene, preceded by an aac(6')-Ib gene. The genetic environment of 
blaVIM-4, blaCMY-2, and sul2 genes showed similarities to the backbone of pKKp4, 
an IncA/C-type plasmid from a Klebsiella pneumoniae strain carrying blaVIM-4 
recovered in Kuwait. This is the first report of blaVIM-4 in Enterobacterales in 
South America. Our results suggest that blaVIM-4 gene was found on an 
IncA/C-type plasmid that could play a role in the spread of VIM-4 carbapenemase 
in Colombia.

DOI: 10.1089/mdr.2021.0031
PMCID: PMC8968847
PMID: 34990286 [Indexed for MEDLINE]

Conflict of interest statement: No competing financial interests exist.